ClinConnect ClinConnect Logo
Search / Trial NCT01604694

Ultrasound-guided Transversus Abdominis Plane Block for Analgesia After Abdominoplasty

Launched by UNIVERSITY HOSPITAL, BORDEAUX · May 23, 2012

Trial Information

Current as of June 25, 2025

Completed

Keywords

Abdominoplasty Transversus Abdominis Plane (Tap) Block Levobupivacaine Placebo

ClinConnect Summary

To determine if TAP block have an analgesic effect in post operative period of abdominoplasty this study was made versus placebo: one group of patients will have a TAP block of levobupivacaine, the second group will have a TAP block with placebo before the surgery. Patient follow up includes data collected before surgery (at pré anesthesic visit and just before surgery) and data collected immediately after surgery (at post operative time) and at distance of the surgery (15 days and 3 months after the surgery). The principal aim is to show if TAP block have an analgesic effect in post operat...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • ASA1 or 2 patients
  • Undergoing abdominoplasty surgery in Centre François Xavier Michelet at Bordeaux University hospital
  • Age \>18 years old
  • Patient agreement by signing an informed consent
  • Exclusion Criteria:
  • Psychiatric or neurological disease
  • Contraindication to regional anesthesia (haemostatic disorders, infection near to insertion point)
  • Double surgery
  • Long term opioid therapy
  • Pregnancy or breast-feeding
  • Allergy to any drug used in anesthesic or surgical procedure

About University Hospital, Bordeaux

The University Hospital of Bordeaux is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the institution integrates cutting-edge scientific inquiry with patient care, fostering an environment that encourages collaboration among multidisciplinary teams. With a commitment to improving treatment outcomes and enhancing patient safety, the University Hospital of Bordeaux plays a pivotal role in the development of new therapies and medical technologies, contributing significantly to the global medical community.

Locations

Bordeaux, , France

Patients applied

0 patients applied

Trial Officials

Antoine BENARD, MD

Study Chair

USMR, University Hospital Bordeaux

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials